63 related articles for article (PubMed ID: 5454548)
21. [A phase I trial of 4'-epiadriamycin].
Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
[TBL] [Abstract][Full Text] [Related]
22. [Bicytopenia (leukopenia and thrombopenia) induced by cimetidine. Apropos of a new case].
Othmani S; M'Saddek F; Zidi B; Louzir B; Boussema E; Bahri M
Therapie; 1992; 47(1):81-2. PubMed ID: 1523603
[No Abstract] [Full Text] [Related]
23. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
24. Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study.
Joseph CD; Praveenkumar V; Kuttan G; Kuttan R
J Exp Clin Cancer Res; 1999 Sep; 18(3):325-9. PubMed ID: 10606177
[TBL] [Abstract][Full Text] [Related]
25. Early-onset leukopenia and severe thrombocytopenia following doxorubicin chemotherapy for tonsillar squamous cell carcinoma in a dog.
Henry CJ; Brewer WG; Stutler SA
Cornell Vet; 1993 Apr; 83(2):163-8. PubMed ID: 8467702
[TBL] [Abstract][Full Text] [Related]
26. [Toxic hematologic side effects of chemotherapy: nursing interventions].
Schewski R
Pflege Z; 2009 Aug; 62(8):466-9. PubMed ID: 19728437
[No Abstract] [Full Text] [Related]
27. Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis.
Numico G; Benasso M; Vannozzi MO; Merlano M; Rosso R; Viale M; Esposito M
Anticancer Res; 1998; 18(2B):1313-8. PubMed ID: 9615808
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).
Domenge C; Hill C; Lefebvre JL; De Raucourt D; Rhein B; Wibault P; Marandas P; Coche-Dequeant B; Stromboni-Luboinski M; Sancho-Garnier H; Luboinski B;
Br J Cancer; 2000 Dec; 83(12):1594-8. PubMed ID: 11189100
[TBL] [Abstract][Full Text] [Related]
29. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of SOAz.
Nasca S; Jezekova D; Coninx P; Garbe E; Carpentier Y; Cattan A
Cancer Treat Rep; 1982 Dec; 66(12):2039-42. PubMed ID: 7139646
[TBL] [Abstract][Full Text] [Related]
31. The leucocyte nadir, a predictor of chemotherapy efficacy?
Kvinnsland S
Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
[No Abstract] [Full Text] [Related]
32. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
[TBL] [Abstract][Full Text] [Related]
33. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
Emerson SS
Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
[TBL] [Abstract][Full Text] [Related]
34. A case of 5-fluorouracil-induced peripheral neuropathy.
Werbrouck BF; Pauwels WJ; De Bleecker JL
Clin Toxicol (Phila); 2008 Mar; 46(3):264-6. PubMed ID: 18344111
[TBL] [Abstract][Full Text] [Related]
35. [The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
Marzetti L; Marcellini G; Midulla C
Clin Ter; 1982 Nov; 103(4):405-9. PubMed ID: 6817959
[No Abstract] [Full Text] [Related]
36. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
[TBL] [Abstract][Full Text] [Related]
37. Predicting fluorouracil toxicity: can we finally do it?
Ezzeldin HH; Diasio RB
J Clin Oncol; 2008 May; 26(13):2080-2. PubMed ID: 18299611
[No Abstract] [Full Text] [Related]
38. Leukopenia and thrombocytopenia due to fusidic acid.
Leibowitz G; Golan D; Yeshurun D; Brezis M
Postgrad Med J; 1991 Jun; 67(788):591-2. PubMed ID: 1924043
[No Abstract] [Full Text] [Related]
39. 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Maiello E; Serravezza G; Giotta F; Testa A; Borsellino N; Pezzella G; Colucci G
Anticancer Res; 1999; 19(2B):1407-10. PubMed ID: 10365114
[TBL] [Abstract][Full Text] [Related]
40. Reversible flu-like syndrome, leukopenia, and thrombocytopenia induced by allopurinol.
Rosenbloom D; Gilbert R
Drug Intell Clin Pharm; 1981 Apr; 15(4):286-7. PubMed ID: 7274044
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
